markets

J. Edward Moreno & Luke Kawa8/14/25

UnitedHealth Group jumps after Berkshire Hathaway discloses stake

UnitedHealth Group soared in after-hours trading after Warren Buffett’s Berkshire Hathaway revealed that it purchased and held 5 million shares of the embattled healthcare giant as of the end of the second quarter, a new position for the conglomerate.

That was a roughly $1.6 billion position as of June 30 — but less now, even after the stock popped nearly 8% higher on this announcement.

It’s been a rough year for health insurers in general, but especially for UnitedHealth. This is a rare highlight during a year to forget. The company cratered after reporting Q1 earnings, saw its CEO leave and pulled guidance shortly thereafter, then fell out of bed again after posting disappointing second-quarter results at the end of July. Oh, and it’s also facing a probe from the Department of Justice into its Medicare Advantage practices.

All this bad news has pushed the company’s stock price down 46% year to date as of Thursday’s close, but that also may have been what made it attractive to a value-oriented shop like Berkshire.

At the end of the second quarter, UNH’s forward price-to-earnings multiple was about 13.1x, versus a trailing five-year average of 19.2x.

Since the end of Q2, its valuation has risen, but for a bad reason: its earnings estimates keep getting chopped.

More Markets

See all Markets

Tasha Matsumoto, Luke Kawa

S&P 500 just barely notches third consecutive all-time high in record day for call volumes

The S&P 500 just barely managed to pull off a three-peat, despite five of the Mag 7 stocks trading lower.

Chicago Bulls players Dennis Rodman (L), Scottie Pippen (C) and Michael Jordan (R) hold three of the team's four recent Larry O'Brien trophies 18 June at a rally for the team in Grant Park in Chicago.

10/3/25

10/3/25

Automakers spike on report that Trump administration is considering tariff relief

The Trump administration is considering significant tariff relief for many major automakers, according to reporting by Reuters.

“The signal to the car companies around the world is, look, you have final assembly in the US, we’re going to reward you,” Ohio Republican Senator Bernie Moreno told Reuters. “For Ford, for Toyota, for Honda, for Tesla, for GM, those are the almost in order the top five domestic content vehicle producers — they’ll be immune to tariffs.”

The senator told Reuters that President Trump could potentially extend the higher levels of tariff offsets announced by the Commerce Department in June.

According to the White House, Moreno’s comments should be considered “speculative,” but shares of vehicle makers including Ford, GM, Toyota, Honda, and Stellantis all rose after the report came out.

markets

Matt Phillips10/3/25

Palantir disputes report of flaws in Army product

Palantir says security vulnerabilities with a prototype battlefield communications product highlighted in a September 5 Army memorandum have already been addressed, according to a Bloomberg report.

The company said any conclusions that the product was seriously flawed, drawn from reports in Reuters and an online publication known as Breaking Defense, were “out of date and inaccurate.”

Separately, Army officials also told Breaking Defense that deficiencies with the battlefield communication product were “mitigated immediately.”

Going into the last hour of trading, Palantir shares were on track for their worst day since August in the wake of the reports.

Palantir Rebuts Claims of Security Flaws After Stock Falls

Palantir Rebuts Claims of Security Flaws After Stock Falls

Separately, Army officials also told Breaking Defense that deficiencies with the battlefield communication product were “mitigated immediately.”

Going into the last hour of trading, Palantir shares were on track for their worst day since August in the wake of the reports.

markets

J. Edward Moreno10/3/25

Novo says it will offer weight-loss pill via telehealth, Bloomberg reports

Hims & Hers slipped after Novo Nordisk’s US head, David Moore, told Bloomberg that the company plans to sell its upcoming weight-loss pill through its current telehealth partners.

The company’s weight-loss pill recently reported encouraging results in a late-stage trial.

Novo currently has partnerships with Hims competitors like Ro and Weight Watchers. Hims had a deal with Novo earlier this year, which blew up epically in less than two months.

Novo Plans to Make Obesity Pill Available Online Once Approved

Novo Plans to Make Obesity Pill Available Online Once Approved

markets

Nia Warfield10/3/25

Shopify soars after Rothschild Redburn hikes price target to $200

Shopify popped nearly 7% Friday afternoon after Rothschild Redburn reiterated its “buy” rating and raised its price target to $200 from $180, tying the highest on Wall Street and about 23% above current levels.

The firm pointed to Shopify’s new partnership with OpenAI’s ChatGPT as a key growth driver, saying it opens up a fresh sales channel that, for now, only Shopify and Etsy merchants can tap into.

Analysts also highlighted that unlike the Magnificent 7 tech names, Shopify can fold AI revenue into its model without heavy capital spending, meaning those contributions could offer a quick boost to free cash flow.

On that note, the firm also bumped its 2025 to 2027 earnings estimates by about 6% to 8%. Shopify shares have already more than doubled over the past year and are up roughly 50% year to date.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.

©2025 Sherwood Media, LLC